Keywords: US, Drug pricing, GAO, House of Representatives

US Committee leaders call for GAO analysis of recent prescription drug price increases

Article | 19 November 2009

Following recent allegations in the New York Times, and rebuttals by the US research-based pharmaceutical industry (The Pharma Letter November 18), leaders of the US House Ways and Means and Energy and Commerce Committees have sent a letter to the Government Accountability Office (GAO) requesting an expedited report on recent trends in prescription drug pricing.

T Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in